She trained for her Ph. Her research has contributed to the current knowledge of the molecular mechanisms involved in the development of T lymphocytes in the human thymus, and to the identification of the signaling pathways whose deregulation is involved in the pathogenesis of T-cell acute lymphoblastic leukaemia T-ALL. Her group has recently pioneered the development of unique models of de novo generation of human T-ALL and preclinical models of immunotherapy, as a proof-of-concept for novel therapeutic developments.
Her research has been funded by several National and International Agencies, and her group has maintained a productive scientific activity, with relevant publications in international journals of high impact, national and international collaborations, and important training activity.
He graduated summa cum laude in Medicine from Harvard Medical School where he also qualified as a Doctor in Sackstein is a international specialist in bone marrow transplantation and its complications as graft versus host disease. Sackstein has been actively involved in the development of the Institute since its inception.
He obtained the title of Doctor in from the University of Salamanca. His activities are focused on research in the clinical area and, above all, in the field of the immune system and cancer, about which he has contributed more than articles to international publications over the last five years. Amongst other posts Prof. At the present time he is a member of the European Group for the Characterisation of Leukaemia.
Her research and studies have taken Prof. Her studies have focused on the identification of recurrent chromosome alterations in leukaemia and malignant lymphomas. The Institute has, in collaboration with many study groups, integrated the cytogenetic and molecular analysis of pilot clinical studies into myelodysplastic syndromes and leukaemia in children and adults.
